Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

NCT03143036 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National University Hospital, Singapore

Collaborators